Brandywine Global Investment Management’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-501,985
Closed -$1.08M 737
2023
Q2
$1.08M Sell
501,985
-2,200
-0.4% -$5.34K 0.01% 626
2023
Q1
$1.47M Hold
504,185
0.01% 601
2022
Q4
$3.46M Hold
504,185
0.03% 465
2022
Q3
$1.6M Buy
504,185
+78,285
+18% +$285K 0.01% 571
2022
Q2
$1.37M Sell
425,900
-64,400
-13% -$187K 0.01% 581
2022
Q1
$1.49M Hold
490,300
0.01% 580
2021
Q4
$2.19M Buy
+490,300
New +$2.4M 0.02% 515

Other funds holding STIM

Brandywine Global Investment Management's STIM Position: Q3 2023 in Review

Brandywine Global Investment Management sold out of Neuronetics (STIM) in Q3 2023, closing a stake of 501,985 shares — an estimated $1.08M sold.

Brandywine Global Investment Management first reported a position in STIM in Q4 2021 and held it in 7 quarters. The position peaked at $3.46M in Q4 2022. 56 funds tracked by Wall St. Rank hold STIM as of Q3 2023.

  • Brandywine Global Investment Management reported no remaining Neuronetics position as of Q3 2023 after selling out during the quarter.
  • Brandywine Global Investment Management sold 501,985 Neuronetics shares in Q3 2023, an estimated $1.08M.
  • Brandywine Global Investment Management first reported a position in Neuronetics in Q4 2021 and held it in 7 quarters.
  • Brandywine Global Investment Management's Neuronetics position peaked at $3.46M in Q4 2022.
  • 56 funds tracked by Wall St. Rank held Neuronetics as of Q3 2023.

Based on Brandywine Global Investment Management's 13F filing for Q3 2023, filed 13 Nov 2023.